Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Jul 10, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$15.3B
sum of reported positions
Reported positions
219
Changes vs prior quarter
213
25 new · 19 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 263 measured positions in 8 quarters, the typical new or larger position finished −6.6 pts against the S&P 500 and 35% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 7.96M | $719M | 4.7% | |
| 2.28M | $365M | 2.4% | |
| 2.12M | $346M | 2.3% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $15.1B | $15.3B |
| Positions | 213 | 219 |
| Biggest line | — | HealthEquity 5% |
| 3.53M |
| $342M |
| 2.2% |
| 637K | $337M | 2.2% |
| 4.36M | $335M | 2.2% |
| 846K | $303M | 2.0% |
| 2.34M | $297M | 1.9% |
| 8.28M | $287M | 1.9% |
| 513K | $278M | 1.8% |
| 869K | $273M | 1.8% |
| 3.24M | $261M | 1.7% |
| 2.87M | $261M | 1.7% |
| 4.7M | $245M | 1.6% |
| 2.75M | $242M | 1.6% |
| 6.07M | $240M | 1.6% |
| 3.6M | $235M | 1.5% |
| 1.48M | $223M | 1.5% |
| 1.59M | $217M | 1.4% |
| 3.63M | $214M | 1.4% |
| 3.25M | $212M | 1.4% |
| 322K | $207M | 1.4% |
| 121K | $205M | 1.3% |
| 1.2M | $199M | 1.3% |
| 693K | $193M | 1.3% |
StoneX Group Inc. (SNEX)
1.18M shares
Horace Mann Educators Corporation (HMN)
1.4M shares
Sailpoint (SAIL)
4.52M shares
Suncrete (RMIX)
2.46M shares
Cimpress (CMPR)
467K shares
Flywire (FLYW)
2.51M shares
Ralliant Corp (RAL)
550K shares
Atlas Energy Solutions, Inc. (AESI)
1.83M shares
Netskope (NTSK)
2.29M shares
Elmet Group (ELMT)
1.22M shares
Tarsus Pharmaceuticals (TARS)
369K shares
A10 Networks, Inc. (ATEN)
416K shares
Suja Life (SUJA)
1.33M shares
Adaptive Biotechnologies (ADPT)
576K shares
Snowflake (SNOW)
46K shares
West Pharmaceutical Services (WST)
25K shares
Lightpath Technologies (LPTH)
520K shares
Lattice Semiconductor (LSCC)
55K shares
Unusual Machines (UMAC)
363K shares
Bob'S Discount Furniture (BOBS)
483K shares
Microsoft (MSFT)
15K shares
Pdd (PDD)
48K shares
Eton Pharmaceuticals (ETON)
93K shares
Circle Internet Group (CRCL)
10K shares
Ridgepost Capital (RPC)
11K shares
